Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-1 vs Melanotan-2: Binding Selectivity Comparison

MC1R (melanocytes) 0.11 0.27 2.5× Eumelanin synthesis, pigmentation Both peptides activate. Minimal difference in tanning efficacy MC3R (hypothalamus, gut) 110 3.5 31× weaker for MT-1 Feeding behavior, inflammation modulation MT-1 produces no appetite effects;

This comparison does not assign a generated winner or score.

  • MC1R (melanocytes)
  • 0.11
  • 0.27
  • 2.5×
  • Eumelanin synthesis, pigmentation
  • Both peptides activate. Minimal difference in tanning efficacy
  • MC3R (hypothalamus, gut)
  • 110
  • 3.5
  • 31× weaker for MT-1
  • Feeding behavior, inflammation modulation
  • MT-1 produces no appetite effects; MT-2 may suppress appetite moderately
  • MC4R (CNS, hypothalamus)
  • 0.95
  • 116× weaker for MT-1
  • Appetite suppression, sexual arousal, cardiovascular tone
  • MT-1 has zero MC4R-mediated effects; MT-2 causes nausea, spontaneous erections, blood pressure changes
  • MC5R (sebaceous glands, muscle)
  • 85
  • 18
  • 5× weaker for MT-1
  • Sebum production, thermoregulation
  • MT-1 minimal sebaceous effects; MT-2 may increase oiliness
  • Bottom Line
  • .
  • Melanotan-1's 1,000-fold MC1R/MC4R selectivity eliminates systemic side effects entirely, making it suitable for clinical use. Melanotan-2's broad receptor activation profile produces faster, stronger tanning but with significant appetite, sexual, and cardiovascular effects that prevent FDA approval.
More references

Related material